MedCity News

Health Tech, Payers

The Reimbursement Challenges Hurting Women’s Health Companies, Per Milken Institute

By Marissa Plescia

BioPharma, Pharma

Vogenx IPO Raises $81M for Trial in Metabolic Disease With No Approved Drugs

Vogenx’s mizagliflozin is heading into Phase 2b testing for post-bariatric hypoglycemia (PBH). Amylyx Pharmaceuticals and Recordati are developing injectable peptide drugs for this metabolic disorder, but Vogenx aims to stand apart by offering patients a different mechanism of action and oral dosing.

By Frank Vinluan

MedCity Influencers

Better Models Won’t Fix Pharma’s AI Problem — Better Terminology Will

The bottleneck in AI-enabled real-world data analysis is not computation, model architecture, or training data volume. It is the semantic layer over which the AI is trying to reason – the place where precise clinical meaning lives.

By Joseph Zabinski

Opinion

The True Cost of Focusing on Cost Instead of Cost-Effectiveness

When payors consider only the cost of the medication and not the cost and risk to the patient, doctor, and healthcare system, the irony is that not only is this terrible for patient health, it can be more costly in the end.

By Alexa B. Kimball

Latest Video

Latest News

Health Tech, Policy, Providers, Legal

Patient Group Sues AMA, Says the Org Shouldn’t Be Charging for CPT Codes

PatientRightsAdvocate.org sued the American Medical Association this week, arguing the trade group has no valid copyright over the CPT codes that providers must use to bill for care. It follows a public letter Senator Bill Cassidy sent to the AMA last year accusing it of "abus[ing] [its] government-backed monopoly by charging exorbitant fees to anyone using the CPT code set."

By Katie Adams

Health Tech, Consumer / Employer

Aligned Marketplace Secures $20M for Advanced Primary Care Marketplace

Venrock led Aligned Marketplace's Series A round. In total, the company has raised $31 million to date.

By Marissa Plescia

presented by

Sponsored Post

From Blind Spots to Better Outcomes: How SNF Data Transparency Strengthens LTSS

What if health plans could identify member decline before an avoidable hospitalization occurs? Real-time clinical visibility into long-stay SNF members uncovers risk earlier and drives better outcomes.

By Anna Keith, Vice President of LTSS Product & Strategy at Centene Corporation, and Phyllis Wojtusik, RN, Executive Vice President of Value-Based Care at Real Time Medical Systems

BioPharma, Pharma

Bristol Myers Squibb Protein Degrader Wins First-in-Class FDA Nod in Multiple Myeloma

Bristol Myers Squibb’s Zenbexus is the first FDA-approved drug in a new class of cancer drugs called CELMoDs. The pharma company is positioning this molecule as a successor to its legacy products for multiple myeloma.

By Frank Vinluan

MedCity Influencers

Healthcare Keeps Buying AI. But Nobody’s Building the Workforce to Run It.

Most younger professionals entering the workforce have little visibility into interoperability, digital health infrastructure, or healthcare data architecture as career pathways. 

By Rachel Dunscombe

Providers, Policy, Payers, Legal

Appeals Court Sides with Providers in No Surprises Act Pay Dispute

A court ruling struck down key parts of how regulators calculate the No Surprises Act's qualifying payment amount, siding with the Texas Medical Association's argument that the formula has historically favored payers in arbitration.

By Katie Adams

presented by

Sponsored Post

The Healthcare Payments Industry Faces a Perception Challenge

Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.

By Lisa Brooks, Vice President, Healthcare Partnerships

Payers, Health Tech

Cotiviti Launches AI Solution to Address Coordination of Benefits Issues

Cotiviti launched an AI-powered coordination of benefits solution that uses enrollment data to identify and resolve coverage issues before claims are submitted.

By Marissa Plescia

BioPharma, Legal

PTC Therapeutics’ $211M Bid Wins Bankruptcy Auction for Sangamo Gene Therapy

Sangamo Therapeutics filed for Chapter 11 bankruptcy in June after its search for strategic alternatives failed to find a path forward for the company. PTC Therapeutics’ auction win brings a Sangamo gene therapy candidate for Fabry disease, a rare inherited disorder with few treatment options.

By Frank Vinluan

presented by

Sponsored Post

Closing the Quality-Affordability Gap in Workplace Mental Health

In an interview, Kyan Health Co-Founder and Chief Commercial Officer Konstantin Struck discussed how Kyan gives mid-market and enterprise employers access to premium workforce mental healthcare, at a price point that is affordable.

By Stephanie Baum

MedCity Influencers

Founders Should Stop Worrying If They’re “AI Enough”

In healthcare, enterprises are moving slower than the hype cycle would lead you to believe. That said, they’re not moving slowly – they are saying yes to AI, as long as it can solve for specific workflow needs.

By Blake Walker

Artificial Intelligence, Startups, Health Tech, Providers

New Startup Launches to Close the Bedside Communication Gap in Hospitals

The 1842 Fund launched a new startup called Suvi Health, which is developing an ambient AI platform that records hospital bedside conversations and turns them into a shared task list for patients and families. The company will pilot the tool with Mayo Clinic starting next month.

By Katie Adams

Consumer / Employer

Report: Employers’ Use of Big Three PBMs Falls in 2026

A new survey finds that employers are moving away from the Big Three PBMs while prioritizing healthcare affordability and transparency.

By Marissa Plescia

BioPharma, Startups

Startup Boulevard Bio Launches With Immune Reset Pioneer Schett as Co-Founder

Deerfield Management formed Boulevard Bio with scientific co-founders Georg Schett and Frank Nestle. The startup’s lead program is in early clinical development for an autoimmune kidney disorder, and could offer dosing advantages over a recently approved Vera Therapeutics medicine and a Vertex Pharmaceuticals drug currently under FDA review.

By Frank Vinluan

MedCity Influencers

Ambulatory Growth Demands a New Operating Model

While organizations have invested heavily in expanding ambulatory networks, many are discovering that operational workflows have not evolved at the same pace. The result is a growing gap between demand and the systems designed to manage it.

By Michelle Skinner

Health Tech, Providers

Health IT Vendor’s Data Breach Exposes Nearly 4M Patient Records

Revenue cycle vendor Unlimited Technology Systems disclosed a ransomware attack affecting 3.8 million patients — the second-largest healthcare data breach reported to HHS this year.

By Katie Adams

Health Tech

NOCD Announces Plans for National Expansion of Intensive Outpatient Therapy

NOCD, a virtual provider for OCD, announced plans to expand its virtual intensive outpatient program for people with severe OCD nationwide.

By Marissa Plescia

BioPharma, Pharma

Infinimmune Secures $75M for a More Human Approach to Developing Better Antibody Drugs

Immunology startup Infinimmune is developing antibody drugs with potential advantages over traditional monoclonal antibodies. The Series A financing will support two lead programs entering the clinic in atopic dermatitis.

By Frank Vinluan